The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others People taking popular new ...

People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Novo Nordisk (NVO) recruits top healthcare analyst Michael Novod, a long time bull of the company, as head of its investor ...

As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are ...

This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...

It might sound shocking to read about such drastic actions, but it’s stories of overweight children being bullied and too ...

After a “horrible experience with Wegovy,” the comedian revealed in March that taking Mounjaro was working “really great” for her.

Somehow, it’s becoming even harder to get a GLP-1.

Amy Schumer's recent appearance in a red Valentino dress highlighted her comfort in her own skin after significant weight ...